A study of Verapamil as a treatment for Diabetes mellitus patients

INTERVENTION: Intervention1: Verapamil tablet: Tablet Verapamil administered orally at a daily dose of 120mg to 240 mg as per need for a duration of 3 months Control Intervention1: routine oral antidiabetic medication: adjusted to control hyperglycemia by dose escalation of existing oral antidiabetic medication ie metformin 500 mg once daily orally will be escalated to 500 mg twice daily orally for 3 months CONDITION: Health Condition 1: E119‐ Type 2 diabetes mellitus without complications Health Condition 2: I10‐ Essential (primary) hypertension PRIMARY OUTCOME: fasting blood sugar, ; HbA1C,C‐peptide,Liver function tests,Serum creatinineTimepoint: fasting blood sugar‐estimated at all visits‐ at day 0,1st month,2nd month,3rd month ; HbA1C,C‐peptide,Liver function tests,Serum creatinine‐at day 0 and at 3rd month SECONDARY OUTCOME: NILTimepoint: NIL INCLUSION CRITERIA: Type two Diabetes mellitus patients whose glycated hemoglobin levels are between more than or equal to 8 percent with existing medication with or without with hypertension